Piramal Pharma receives USFDA EIR for US facility; inspection closed with VAI
Piramal Pharma gets USFDA EIR with VAI for its Lexington plant, closing the 2025 inspection, shares edge up though stock remains 34% down over the past year.
Uncategorized
Oil unlikely to fall below $80/bbl amid supply disruptions: Maulik Patel
Maulik Patel, Head of Research, Equirus Investment Securities, said growth in CNG volumes is slowing, especially in key markets like Delhi. Policy reforms such as bringing gas under GST and reducing taxes could support demand. Investors are advised to consider…
Energy prices lift US inflation; fuel costs seen as ‘tax’ on consumers: William Lee
US inflation rose in March due to higher energy prices, while consumer confidence weakened and GDP growth slowed. Economists say the impact on household income and jobs is a bigger concern than inflation itself. Market indicators suggest the price rise…
Paytm’s profit, core-EBITDA may quadruple in three years, as per this analyst; 30% upside projected
Paytm’s sharp focus on digitizing SME merchants improved monetization capability, thereby driving strong revenue growth, Haitong said, adding that there are structural levers in play to drive the improvement in Paytm’s payments margin due to the rise in mix of…
‘Concerns Overdone’: Eternal shares are down 15% in 2026 but Goldman sees stock at ₹350
On competition, Goldman Sachs expects Blinkit to continue gaining share from Swiggy, but acknowledged that growth may have been impacted in recent months due to heightened competition from new entrants as well as existing players.
Avenue Supermarts shares could fall 50% in a ‘bear case’ scenario, Emkay warns
Emkay wrote in its note that with a forward price-to-earnings valuation of 70 times, the stock is pricing in a business that DMart needs to become and not what it currently is.
Rupee weakens 55 paise against dollar: What’s weighing on the currency
Rupee opens sharply weaker at 93.28 per dollar as crude jumps and risk aversion rises, Trump Hormuz blockade warning lifts oil, analysts see continued rupee volatility.
JPMorgan is bullish, neutral and bearish on these three housing financiers; Check price targets
JPMorgan wrote in its note that the system mortgage should grow between 8% – 10% over the next three to five years, which has come off to 9% in February 2026 compared to 11% in the last three years.
Explained — Why Tata Chemicals shares surged as much as 11% in a weak market
Under the current rules, Tata Sons is classified as an upper-layer NBFC, which mandates it to list by September 30,2025. Tata Sons is in fact, the only one among the 15 upper-layer NBFCs that are yet to comply with this…
These auto stocks are the likely beneficiaries of the CAFE 2027 draft norms
The changes are seen as positive for M&M and Hyundai, as meeting CAFE norms now appears easier and less of a risk. These companies are also unlikely to alter their product strategies to include hybrids.